Solid Organ Transplant Graft-Versus-Host Disease in a Kidney/Pancreas Transplant Patient: Use of Chimerism Testing and a Rare Presentation of Cutaneous GVHD

Table 1

Chimerism data before and after ATG administration.

		Postpancreas transplant, prior to ATG ()		Postpancreas transplant, two months after ATG ()	Postpancreas transplant, four months after ATG ()
Lymphoid (CD3+)	Pancreas transplant ()	3% recipient; 96% donor (pancreas)	ATG ()	87% recipient; 13% donor (pancreas)	100% recipient
Myeloid (CD33/66b+)		100% recipient		100% recipient	100% recipient